- Home
- MLNK vs INVA Comparison
MLNK vs INVA Comparison
Compare MLNK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLNK
- INVA
- Stock Information
- Founded
- MLNK 1998
- INVA 1996
- Country
- MLNK United States
- INVA United States
- Employees
- MLNK N/A
- INVA N/A
- Industry
- MLNK Computer Software: Prepackaged Software
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- MLNK Technology
- INVA Health Care
- Exchange
- MLNK Nasdaq
- INVA Nasdaq
- Market Cap
- MLNK 1.5B
- INVA 1.3B
- IPO Year
- MLNK 2021
- INVA 2004
- Fundamental
- Price
- MLNK $19.99
- INVA $16.67
- Analyst Decision
- MLNK Hold
- INVA Buy
- Analyst Count
- MLNK 8
- INVA 5
- Target Price
- MLNK $21.50
- INVA $35.60
- AVG Volume (30 Days)
- MLNK 742.4K
- INVA 716.9K
- Earning Date
- MLNK 11-06-2025
- INVA 11-05-2025
- Dividend Yield
- MLNK N/A
- INVA N/A
- EPS Growth
- MLNK N/A
- INVA N/A
- EPS
- MLNK N/A
- INVA 0.53
- Revenue
- MLNK $325,891,000.00
- INVA $370,229,000.00
- Revenue This Year
- MLNK $6.70
- INVA $7.98
- Revenue Next Year
- MLNK $5.44
- INVA $11.60
- P/E Ratio
- MLNK N/A
- INVA $31.20
- Revenue Growth
- MLNK 5.96
- INVA 12.02
- 52 Week Low
- MLNK $15.49
- INVA $16.59
- 52 Week High
- MLNK $25.22
- INVA $22.00
- Technical
- Relative Strength Index (RSI)
- MLNK 71.37
- INVA 25.43
- Support Level
- MLNK $19.92
- INVA $17.01
- Resistance Level
- MLNK $20.01
- INVA $17.73
- Average True Range (ATR)
- MLNK 0.03
- INVA 0.49
- MACD
- MLNK -0.06
- INVA -0.12
- Stochastic Oscillator
- MLNK 75.00
- INVA 2.88
About MLNK MeridianLink Inc.
MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.